ArticleAmerican heart journal2022

Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial.

Connie N Hess et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.